Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × toripalimab × Clear all

NCT05628922 2022-11-29

Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICT

Phase 2 Recruiting

Nasopharyngeal Neoplasms